General American Investors’s Repros Therapeutics Inc. RPRX Stock Holding History

General American Investors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-237,504	Closed	-$76K	–	72
2017 Q3	$76K	Sell	237,504 -282,325	-54%	-$99K	0.01%	63
2017 Q2	$239K	Sell	519,829 -69,939	-12%	-$50.8K	0.02%	57
2017 Q1	$708K	Hold	589,768	–	–	0.07%	58
2016 Q4	$778K	Sell	589,768 -121,355	-17%	-$211K	0.08%	61
2016 Q3	$1.49M	Buy	711,123 +315,000	+80%	+$623K	0.15%	58
2016 Q2	$638K	Hold	396,123	–	–	0.07%	55
2016 Q1	$384K	Hold	396,123	–	–	0.04%	54
2015 Q4	$479K	Sell	396,123 -112,937	-22%	-$363K	0.04%	55
2015 Q3	$3.78M	Sell	509,060 -92,493	-15%	-$707K	0.34%	54
2015 Q2	$4.3M	Buy	601,553 +93,178	+18%	+$726K	0.35%	54
2015 Q1	$4.37M	Hold	508,375	–	–	0.36%	52
2014 Q4	$5.07M	Buy	508,375 +58,900	+13%	+$502K	0.41%	51
2014 Q3	$4.45M	Buy	449,475 +303,584	+208%	+$4.5M	0.35%	53
2014 Q2	$2.52M	Buy	145,891 +43,391	+42%	+$707K	0.21%	55
2014 Q1	$1.82M	Hold	102,500	–	–	0.15%	57
2013 Q4	$1.88M	Hold	102,500	–	–	0.15%	57
2013 Q3	$2.75M	Buy	+102,500	New	+$2.2M	0.24%	52

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

General American Investors's RPRX Position: Q4 2017 in Review

General American Investors sold out of Repros Therapeutics Inc. (RPRX) in Q4 2017, closing a stake of 237,504 shares — an estimated $76K sold.

General American Investors first reported a position in RPRX in Q3 2013 and held it in 17 quarters. The position peaked at $5.07M in Q4 2014. 30 funds tracked by Wall St. Rank hold RPRX as of Q4 2017.

General American Investors reported no remaining Repros Therapeutics Inc. position as of Q4 2017 after selling out during the quarter.
General American Investors sold 237,504 Repros Therapeutics Inc. shares in Q4 2017, an estimated $76K.
General American Investors first reported a position in Repros Therapeutics Inc. in Q3 2013 and held it in 17 quarters.
General American Investors's Repros Therapeutics Inc. position peaked at $5.07M in Q4 2014.
30 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2017.

Based on General American Investors's 13F filing for Q4 2017, filed 13 Feb 2018.